ストックスクリーナーアプリを入手
1.61
1.23%
-0.02
アフターアワーズ：
1.59
-0.02
-1.24%
前日終値:
$1.63
開ける：
$1.63
24時間の取引高:
144.22K
Relative Volume:
0.07
時価総額：
$5.29M
収益：
$12.99M
当期純損益:
$-23.72M
株価収益率:
-0.0166
EPS:
-97.2514
ネットキャッシュフロー:
$-23.28M
1週間 パフォーマンス:
-1.83%
1か月 パフォーマンス:
-34.29%
6か月 パフォーマンス:
-97.09%
1年 パフォーマンス:
-99.36%
1日の値動き範囲:
$1.54
$1.6399
1週間の範囲:
$1.54
$1.73
52週間の値動き範囲:
$1.54
$381.10
Aptevo Therapeutics Inc Stock (APVO) Company Profile
APVO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
1.61 | 5.36M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2018-11-05 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-10-05 | 再開されました | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc (APVO) 最新ニュース
Can technical indicators confirm Aptevo Therapeutics Inc.’s reversalJuly 2025 Sentiment & Community Trade Idea Sharing - Newser
Automated trading signals detected on Aptevo Therapeutics Inc.Fed Meeting & Weekly Momentum Picks - Newser
Aptevo Therapeutics Inc. stock daily chart insightsWeekly Market Report & Long Hold Capital Preservation Tips - Newser
Is Aptevo Therapeutics Inc. a speculative investmentJuly 2025 Breakouts & High Accuracy Investment Signals - خودرو بانک
Does Aptevo Therapeutics Inc. have a sustainable dividendJuly 2025 Price Swings & Comprehensive Market Scan Reports - خودرو بانک
Will Aptevo Therapeutics Inc. benefit from sector rotationJuly 2025 Weekly Recap & Daily Oversold Bounce Ideas - خودرو بانک
What is Aptevo Therapeutics Inc.’s book value per shareEarnings Trend Report & Reliable Breakout Stock Forecasts - خودرو بانک
Can Aptevo Therapeutics Inc. navigate macro headwindsTrade Entry Report & Daily Volume Surge Trade Alerts - خودرو بانک
Ranking Aptevo Therapeutics Inc. among high performing stocks via toolsPortfolio Return Report & High Accuracy Swing Entry Alerts - Newser
Visual analytics tools that track Aptevo Therapeutics Inc. performance2025 Short Interest & Real-Time Volume Triggers - Newser
With New Cash Aptevo Goes It Alone on Prostate Drug, Shares UpBiotech Movers - TheStreet
What to do if you’re stuck in Aptevo Therapeutics Inc.Weekly Trade Summary & Low Drawdown Investment Strategies - Newser
News impact scoring models applied to Aptevo Therapeutics Inc.2025 Historical Comparison & Real-Time Stock Entry Alerts - Newser
Foremost Clean Energy and Aptevo Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
Aptevo Therapeutics unveils new trispecific immune cell engagers - BioWorld MedTech
How institutional ownership impacts Aptevo Therapeutics Inc. stockMarket Activity Recap & Free Daily Entry Point Trade Alerts - Newser
Evaluating Aptevo Therapeutics Inc. with trendline analysisIPO Watch & Target Return Focused Picks - Newser
Aptevo expands cancer pipeline with two new trispecific therapies By Investing.com - Investing.com Canada
Is Aptevo Therapeutics Inc. forming bullish engulfing patternsJuly 2025 Final Week & High Conviction Investment Ideas - khodrobank.com
Can Aptevo Therapeutics Inc. expand into new marketsMarket Growth Report & Low Drawdown Trading Strategies - خودرو بانک
Why Aptevo Therapeutics Inc. is moving todayRecession Risk & AI Based Trade Execution Alerts - Newser
What momentum shifts mean for Aptevo Therapeutics Inc.July 2025 EndofMonth & Weekly Top Gainers Alerts - Newser
Aptevo Therapeutics Expands Anti-Cancer Pipeline with Patents - TipRanks
How cyclical is Aptevo Therapeutics Inc.’s revenue streamJuly 2025 Sector Moves & Fast Gaining Stock Reports - خودرو بانک
Aptevo expands cancer pipeline with two new trispecific therapies - Investing.com
Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules - ACCESS Newswire
First-Ever Triple-Action Cancer Therapy: Aptevo's New Trispecifics Target Tumors 3 Ways at Once - Stock Titan
What is Aptevo Therapeutics Inc. s 5 year growth outlookMarket Movers & Verified Swing Trading Watchlists - خودرو بانک
Risk vs reward if holding onto Aptevo Therapeutics Inc.Trade Exit Summary & Technical Confirmation Trade Alerts - Newser
Real time social sentiment graph for Aptevo Therapeutics Inc.Buy Signal & Weekly Breakout Opportunity Watchlist - Newser
Can volume confirm reversal in Aptevo Therapeutics Inc.July 2025 Catalysts & Reliable Entry Point Trade Alerts - Newser
Real time pattern detection on Aptevo Therapeutics Inc. stockEntry Point & Scalable Portfolio Growth Ideas - Newser
Using data models to predict Aptevo Therapeutics Inc. stock movementJuly 2025 Sector Moves & Risk Controlled Stock Alerts - Newser
Is Aptevo Therapeutics Inc. a defensive stockJuly 2025 Price Swings & AI Driven Price Forecasts - خودرو بانک
How to manage a losing position in Aptevo Therapeutics Inc.Profit Target & Daily Technical Forecast Reports - Newser
How moving averages guide Aptevo Therapeutics Inc. trading2025 Technical Patterns & Consistent Income Trade Recommendations - Newser
Is Aptevo Therapeutics Inc. currently under institutional pressureJuly 2025 Earnings & Intraday High Probability Setup Alerts - خودرو بانک
Historical volatility pattern of Aptevo Therapeutics Inc. visualizedGap Down & Real-Time Stock Entry Alerts - Newser
Will breakout in Aptevo Therapeutics Inc. lead to full recovery2025 Year in Review & Stock Timing and Entry Methods - Newser
Institution Moves: What drives Aptevo Therapeutics Inc.’s stock price2025 Growth vs Value & Accurate Buy Signal Notifications - خودرو بانک
What drives Aptevo Therapeutics Inc.’s stock priceWeekly Risk Report & Expert Approved Momentum Trade Ideas - خودرو بانک
Aptevo Therapeutics Inc (APVO) 財務データ
収益
当期純利益
現金流量
EPS
1.40%
大文字化:
|
ボリューム (24 時間):